title: Iron Oxide Hyperthermia And Radiation Cancer Treatment.
abstract: It is established that heat can enhance the effect of radiation cancer treatment. Due to the ability to localize thermal energy using nanoparticle hyperthermia, as opposed to other, less targeted, hyperthermia modalities, it appears such enhancement could be accomplished without complications normally associated with systemic or regional hyperthermia. This study employs non-curative (suboptimal), doses of heat and radiation, in an effort to determine the therapeutic enhancement potential for IONP hyperthermia and radiation.
  
  
  METHODS
  MTG-B murine breast adenocarcinoma cell are inoculated into the right flanks of female CH3/HEJ mice and grown to volumes of 150mm3 +/-40 mm3. A single dose of 15 Gy (6 MeV) radiation was uniformly delivered to the tumor. A pre-defined thermal dose is delivered by direct injection of iron oxide nanoparticles into the tumor. By adjusting the field strength of the 160 KHz alternating magnetic field (AMF) an intra-tumoral temperature between 41.5 and 43 degrees Celsius was maintained for 10min. The alternating magnetic field was delivered by a water-cooled 36mm diameter square copper tube induction coil operating at 160 kHz with variable magnet field strengths up to 450 Oe. The primary endpoint of the study is the number of days required for the tumor to achieve a volume 3 fold greater than the volume at the time of treatment (tumor regrowth delay).
  
  
  RESULTS
  Preliminary results suggest the addition of a modest IONP hyperthermia to 15 Gy radiation achieved an approximate 50% increase in tumor regrowth delay as compared to a 15 Gy radiation treatment alone. The therapeutic effects of IONP heat and radiation combined were considered additive, however in mice that demonstrated complete response (no tumor present after 30 days), the effect was considered superadditive or synergistic. Although this data is very encouraging from a multimodality cancer therapy standpoint, additional temporal and dose related information is clearly necessary to optimize the therapy.
authors.affiliation: Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA.
authors.forename: Sm
authors.initials: S
authors.lastname: Cassim
authors.affiliation: Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03766 USA ; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA.
authors.forename: Aj
authors.initials: A
authors.lastname: Giustini
authors.affiliation: Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA.
authors.forename: Aa
authors.initials: A
authors.lastname: Petryk
authors.affiliation: Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03766 USA.
authors.forename: Ra
authors.initials: R
authors.lastname: Strawbridge
authors.affiliation: Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03766 USA ; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA.
authors.forename: Pj
authors.initials: P
authors.lastname: Hoopes
keywords: AMF; HT-29; Iron oxide; MTG-B; TEM; adenocarcinoma; murine; nanoparticle; transmission electron microscopy